Company Filing History:
Years Active: 2017-2019
Title: Daniela Kathmann: Innovator in Biotech
Introduction
Daniela Kathmann is a prominent inventor based in Halle/Saale, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of proNGF mutants for medical applications. With a total of 2 patents, her work is paving the way for advancements in human health.
Latest Patents
Her latest patents focus on the production of biologically active human beta-NGF from inactive proNGF mutants. The inventions disclose methods for preparing these mutants, which are crucial for producing human beta-NGF. Specifically, her work involves substituting amino acids at the native protease cleavage site, ensuring that Arg or Lys are not present at critical positions in the proNGF sequence.
Career Highlights
Daniela is currently employed at Wacker Chemie AG, where she continues to innovate and develop new biotechnological solutions. Her expertise in the field has led to significant advancements in the understanding and application of proNGF mutants.
Collaborations
Throughout her career, Daniela has collaborated with notable colleagues, including Susan Lorey and Bernhard Janowski. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Daniela Kathmann is a trailblazer in biotechnology, with her innovative work on proNGF mutants making a substantial impact in the field. Her contributions are vital for future developments in medical applications.